


The aim of the Fund is to provide a growing income with capital growth.
| Name | % Net Assets | 
|---|---|
| Vodafone Group PLC | 4.1% | 
| GlaxoSmithKline PLC | 3.2% | 
| BT Group PLC | 2.7% | 
| Legal & General Group PLC | 2.6% | 
| AstraZeneca PLC | 2.5% | 
| Unilever PLC | 2.5% | 
| Imperial Tobacco Group PLC | 2.4% | 
| British American Tobacco PLC | 2.2% | 
| RSA Insurance Group PLC | 1.9% | 
| BAE Systems PLC | 1.7% | 
| Key | % Net Assets | 
|---|---|
| 4.1% | |
| 3.2% | |
| 2.7% | |
| 2.6% | |
| 87.4% | 
| Date | 09-Apr-2021 | 
|---|---|
| Bid | 77.80p | 
| Offer | 77.80p | 
| Currency | GBP | 
| Change | 0.13p | 
| % | 0.17% | 
| YTD change | 77.80p | 
| YTD % | n/a | 
| Fund Inception | 26/08/1997 | 
|---|---|
| Fund Manager | Chris White | 
| TER | 1.81 (30-Mar-2012) | 
| Minimum Investment | |
|---|---|
| Initial | £2000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 3.75% | 
| Annual Mang't | 0.25% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.07 | 
You are here: research